DE2856534A1 - 11-alkanoyl-4''desoxy-4''-isonitrilo-oleandomycin-derivate und ihre verwendung - Google Patents

11-alkanoyl-4''desoxy-4''-isonitrilo-oleandomycin-derivate und ihre verwendung

Info

Publication number
DE2856534A1
DE2856534A1 DE19782856534 DE2856534A DE2856534A1 DE 2856534 A1 DE2856534 A1 DE 2856534A1 DE 19782856534 DE19782856534 DE 19782856534 DE 2856534 A DE2856534 A DE 2856534A DE 2856534 A1 DE2856534 A1 DE 2856534A1
Authority
DE
Germany
Prior art keywords
oleandomycin
deoxy
alkanoyl
isonitrilo
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19782856534
Other languages
German (de)
English (en)
Inventor
Gene Michael Bright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE2856534A1 publication Critical patent/DE2856534A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19782856534 1978-01-03 1978-12-28 11-alkanoyl-4''desoxy-4''-isonitrilo-oleandomycin-derivate und ihre verwendung Pending DE2856534A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/866,721 US4124755A (en) 1978-01-03 1978-01-03 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives

Publications (1)

Publication Number Publication Date
DE2856534A1 true DE2856534A1 (de) 1979-07-05

Family

ID=25348249

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782856534 Pending DE2856534A1 (de) 1978-01-03 1978-12-28 11-alkanoyl-4''desoxy-4''-isonitrilo-oleandomycin-derivate und ihre verwendung

Country Status (11)

Country Link
US (1) US4124755A (US20050265960A1-20051201-C00007.png)
JP (1) JPS54109991A (US20050265960A1-20051201-C00007.png)
BE (1) BE873266A (US20050265960A1-20051201-C00007.png)
DE (1) DE2856534A1 (US20050265960A1-20051201-C00007.png)
DK (1) DK1579A (US20050265960A1-20051201-C00007.png)
FR (1) FR2413402A1 (US20050265960A1-20051201-C00007.png)
GB (1) GB2011890B (US20050265960A1-20051201-C00007.png)
IE (1) IE47797B1 (US20050265960A1-20051201-C00007.png)
IT (1) IT1162702B (US20050265960A1-20051201-C00007.png)
LU (1) LU80742A1 (US20050265960A1-20051201-C00007.png)
NL (1) NL7900005A (US20050265960A1-20051201-C00007.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters
US4300400A (en) * 1979-04-05 1981-11-17 Westinghouse Electric Corp. Acoustic flowmeter with Reynolds number compensation
US4336368A (en) * 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
ATE468119T1 (de) 2006-06-12 2010-06-15 Univ Ramot Verfahren zur behandlung von krebs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4125705A (en) * 1977-02-04 1978-11-14 Pfizer Inc. Semi-synthetic 4-amino-oleandomycin derivatives
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin
SE446340B (sv) * 1977-05-11 1986-09-01 Pfizer Sett att framstella halvsyntetiska 4"-sulfonylamino-oleandomycinderivat
US4124913A (en) * 1977-06-29 1978-11-14 Bissell, Inc. Floor sweeper with unitary frame
US4098993A (en) * 1977-07-25 1978-07-04 Pfizer Inc. Semi-synthetic 4-ureido-oleandomycin derivatives

Also Published As

Publication number Publication date
BE873266A (fr) 1979-07-02
LU80742A1 (fr) 1979-09-07
GB2011890B (en) 1982-05-26
NL7900005A (nl) 1979-07-05
DK1579A (da) 1979-07-04
IT7919012A0 (it) 1979-01-02
IE790004L (en) 1979-07-03
FR2413402B1 (US20050265960A1-20051201-C00007.png) 1981-03-20
IT1162702B (it) 1987-04-01
GB2011890A (en) 1979-07-18
IE47797B1 (en) 1984-06-27
US4124755A (en) 1978-11-07
FR2413402A1 (fr) 1979-07-27
JPS54109991A (en) 1979-08-29
JPS5648519B2 (US20050265960A1-20051201-C00007.png) 1981-11-16

Similar Documents

Publication Publication Date Title
DE2819217A1 (de) Neue antitumoranthracycline
DE1518002B2 (de) Isoflavane und Isoflavene und Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DD211565A5 (de) Verfahren zur herstellung von 4"-epi-erythromycin a und derivaten hiervon als brauchbare antibakterielle mittel
DE2427096A1 (de) 2-deoxystreptamin-aminoglycoside und verfahren zu ihrer herstellung
DE2750812A1 (de) Anthracyclinderivate und verfahren zu deren herstellung
DE2900118C2 (US20050265960A1-20051201-C00007.png)
DE2425983A1 (de) Cholinsulfonatderivate und verfahren zu ihrer herstellung
DE2740950A1 (de) Verfahren zur herstellung von flavonen
DE2804509C2 (de) 4"-Amino-oleandomycin-Derivate und diese Verbindungen enthaltende antibakterielle Mittel
DE2856534A1 (de) 11-alkanoyl-4''desoxy-4''-isonitrilo-oleandomycin-derivate und ihre verwendung
DE2510602A1 (de) Gentamin-derivate und deren salze, herstellungsverfahren dafuer und pharmazeutische zusammensetzungen
DE2117442B2 (de) Verfahren zur Herstellung eines a -e-Desoxytetracyclins
DE2804507C2 (de) 4"-Desoxy-4"-amino-erythromycin-A und dessen Derivate sowie diese Verbindungen enthaltende antibakterielle Mittel
DE1228254B (de) Verfahren zur Herstellung antibakteriell wirksamer Dihydrofusidinsaeure bzw. -salze
DE3247175A1 (de) Dihydro- und tetrahydromonacolin l, ihre metallsalze und alkylester sowie verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2900120C2 (US20050265960A1-20051201-C00007.png)
DE2900119C2 (de) 4''-Desoxy-4''-carbamat- und -dithiocarbamat-Derivate des 11-Acetyl-oleandomycins und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
AT360159B (de) Verfahren zur herstellung von neuen 4''-amino- -oleandomycinen
AT301030B (de) Verfahren zur herstellung von neuen spiramycinderivaten
AT361629B (de) Verfahren zur herstellung von neuen 4''- -erythromycin-a-derivaten
AT371481B (de) Verfahren zur herstellung von neuen 4''-deoxy-4''-acylamidoderivaten von erythromycin
DE3041130A1 (de) Antibiotisch wirksames macrolid
CH449006A (de) Verfahren zur Herstellung von Fusidinsäure- und Dihydrofusidinsäurederivaten
DE2640123A1 (de) Maleinsaeuresalz von 2-phenyl-6-(1-hydroxy-2-tert.-butylaminoaethyl)-4h-pyrido- (3,2-d)-1,3-dioxin, ein verfahren zur herstellung desselben sowie ein verfahren zur herstellung von 2-hydroxymethyl-3- hydroxy-6-(1-hydroxy-2-tert.-butylaminoaethyl)-pyridin
DE2060205A1 (de) Antibiotisch wirksame Dibenzofuranderivate und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
OHW Rejection